This trial will compare single-injection vs multiple injections of thoracic paravertebral block for anesthesia during breast cancer surgery. It may reduce post-op nausea, narcotic use and hospital stay, and improve patient satisfaction.
- Breast Cancer
2 Primary · 9 Secondary · Reporting Duration: Intraoperative, about 30 minutes
2 Treatment Groups
Thoracic paravertebral block multiple (3) injections
1 of 2
Thoracic paravertebral block single injection
1 of 2
68 Total Participants · 2 Treatment Groups
Primary Treatment: Thoracic paravertebral block single injection · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment still open for this clinical trial?
"Affirmative. The clinicaltrials.gov database indicates that this medical experiment, which was initially published on November 4th 2022, is presently enlisting volunteers. Approximately 68 patients must be recruited from 1 different healthcare facility." - Anonymous Online Contributor
How many participants are eligible for enrollment in this trial?
"Affirmative, the clinicaltrials.gov entry for this trial confirms it is currently enrolling participants. This research project was initially listed on November 4th 2022 and last modified on February 1st 2023. Sixty-eight patients are required to join from a single medical facility." - Anonymous Online Contributor
Which results is this trial attempting to achieve?
"This trial aims to assess total amount of ketamine used during the intraoperative period, which is about 30 minutes. Secondary objectives include evaluating adverse effects such as hypotension and vagal reaction; pre-surgical block levels with an ice test after 20 minutes post-block; and postoperative pain at rest and on movement (VAS) in PACU or day surgery unit every 15 minutes until discharge." - Anonymous Online Contributor